Double stranded RNA‑dependent protein kinase promotes the tumorigenic phenotype in HepG2 hepatocellular carcinoma cells by activating STAT3

Oncology Letters

Volumn 8, Issue 6, 2014, Pages 2762-2768

  Wang, Xun ^a   Dong, Jia Hong ^a   Zhang, Wen Zhi ^a   Leng, Jian Jun ^a   Cai, Shou Wang ^a   Chen, Ming Yi ^a   Yang, Xuerui ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b China   (China)

Author keywords

Double stranded RNA dependent protein kinase; Hepatocellular carcinoma; HepG2; Signal transducer and activator of transcription 3; Tumorigenesis

Indexed keywords

LENTIVIRUS VECTOR; PROTEIN KINASE R; SMALL INTERFERING RNA; STAT3 PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CASE REPORT; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR VOLUME; WESTERN BLOTTING; XENOGRAFT;

EID: 84908046615     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2560     Document Type: Article

References (34)

1. Barber GN: The dsRNA-dependent protein kinase, PKR and cell death. Cell Death Differ 12: 563-570, 2005.
2. Zhang F, Romano PR, Nagamura-Inoue T, et al: Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem 276: 24946-24958, 2001.
3. Taylor SS, Haste NM and Ghosh G: PKR and eIF2alpha: integration of kinase dimerization, activation, and substrate docking. Cell 122: 823-825, 2005.
4. Williams BR: Signal integration via PKR. Sci STKE 2001: re2, 2001.
5. Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD: How cells respond to interferons. Annu Rev Biochem 67: 227-264, 1998.
6. Koromilas AE, Roy S, Barber GN, Katze MG and Sonenberg N: Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257: 1685-1689, 1992.
7. Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG: Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90: 232-236, 1993.
8. Roh V, Laemmle A, Von Holzen U, et al: Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer Gene Ther 15: 636-644, 2008.
9. Hiasa Y, Kamegaya Y, Nuriya H, et al: Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 98: 2528-2534, 2003.
10. Delhem N, Sabile A, Gajardo R, et al: Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene 20: 5836-5845, 2001.
11. Mohamed AA, Nada OH and El Desouky MA: Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis. Diagn Pathol 7: 103, 2012.
12. Kim SH, Forman AP, Mathews MB and Gunnery S: Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 19: 3086-3094, 2000.
13. Kim SH, Gunnery S, Choe JK and Mathews MB: Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene 21: 8741-8748, 2002.
14. Delgado André N and De Lucca FL: Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: Possible role of NF-kappaB. Cancer Lett 258: 118-125, 2007.
15. Donzé O, Deng J, Curran J, et al: The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J 23: 564-571, 2004.
16. Yang X and Chan C: Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2. Cell Res 19: 469-486, 2009.
17. Kumar A, Yang YL, Flati V, et al: Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J 16: 406-416, 1997.
18. Cuddihy AR, Li S, Tam NW, et al: Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol 19: 2475-2484, 1999.
19. Deb A, Zamanian-Daryoush M, Xu Z, Kadereit S and Williams BR: Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. EMBO J 20: 2487-2496, 2001.
20. Wang S, Raven JF, Baltzis D, et al: The catalytic activity of the eukaryotic initiation factor-2alpha kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase. J Biol Chem 281: 9439-9449, 2006.
21. Calvisi DF, Ladu S, Gorden A, et al: Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 130: 1117-1128, 2006.
22. He G, Yu GY, Temkin V, et al: Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 17: 286-297, 2010.
23. Carro MS, Lim WK, Alvarez MJ, et al: The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325, 2010.
24. Maeda S, Kamata H, Luo JL, Leffert H and Karin M: IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977-990, 2005.
25. Maeda S, Hikiba Y, Sakamoto K, et al: Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology 50: 1851-1860, 2009.
26. He G and Karin M: NF-kappaB and STAT3 - key players in liver inflammation and cancer. Cell Res 21: 159-168, 2011.
27. Papadakis AI, Paraskeva E, Peidis P, et al: eIF2α Kinase PKR Modulates the Hypoxic Response by Stat3-Dependent Transcriptional Suppression of HIF-1α. Cancer Res 70: 7820-7829, 2010.
28. Proud CG: PKR: a new name and new roles. Trends Biochem Sci 20: 241-246, 1995.
29. Kumar A, Haque J, Lacoste J, Hiscott J and Williams BR: Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci USA 91: 6288-6292, 1994.
30. Gil J, Alcamí J and Esteban M: Activation of NF-kappa B by the dsRNA-dependent protein kinase, PKR involves the I kappa B kinase complex. Oncogene 19: 1369-1378, 2000.
31. Zhou HR, Lau AS and Pestka JJ: Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response. Toxicol Sci 74: 335-344, 2003.
32. Xu Z and Williams BR: The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR. Mol Cell Biol 20: 5285-5299, 2000.
33. Donzé O, Jagus R, Koromilas AE, Hershey JW and Sonenberg N: Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 14: 3828-3834, 1995.
34. Watanabe T, Hiasa Y, Tokumoto Y, et al: Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection. PLoS One 8: e67750, 2013.